SMTL ID : 6tns.1

PI3K delta in complex with 2methoxyN[2methoxy5(7{[(2R)4(oxetan3 yl)morpholin2yl]methoxy}1,3dihydro2 benzofuran5yl)pyridin3yl]ethane1 sulfonamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x NQ5: 2-methoxy-~{N}-[2-methoxy-5-[7-[[(2~{R})-4-(oxetan-3-yl)morpholin-2-yl]methoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]ethanesulfonamide(Non-covalent)

NQ5.1: 19 residues within 4Å: Chain A: M.648, S.650, P.654, W.656, I.673, K.675, D.683, Y.709, I.721, E.722, V.723, V.724, S.727, D.728, T.729, N.732, M.796, I.806, D.807 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.673, A:I.721, A:I.806, A:I.806 Hydrogen bonds: A:S.650, A:K.675, A:K.675, A:D.807 Water bridges: A:S.650, A:Y.709

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Henley, Z.A. et al., Optimization of Orally Bioavailable PI3K delta Inhibitors and Identification of Vps34 as a Key Selectivity Target. J.Med.Chem. (2020)

Release Date

2020-01-01

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform

Related Entries With Identical Sequence